Sichuan Kelun-Biotech Biopharmaceutical
$472.20Change from previous close: −3.04%Absolute change: −$14.80
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- $112.87B
- Enterprise value
- $105.41B
- P/E (trailing 12 months)
- 621.3
- Forward P/E
- 135.6
- Price/book
- 17.6
- Price/sales
- 54.1
- EV/EBITDA
- 1,781.6
- EV/revenue
- 50.5
Profitability and growth
- Gross margin
- 74.6%
- Operating margin
- 22.4%
- Net margin
- 7.2%
- ROE
- 2.9%
- ROA
- -0.0%
- ROIC
- -0.0%
- Revenue growth (year over year)
- 2.9%
Financial health
- Total cash
- $4.78B
- Total debt
- $81.35M
- Debt/equity
- 0.02
- Current ratio
- 6.34
- Quick ratio
- 5.98
- Altman Z-Score
- 55.8
- Piotroski F-Score
- 5.00
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $619.67
- Median price target
- $625.00
- High price target
- $765.30
- Low price target
- $520.00
- Analysts with a price target
- 19
- Consensus
- Strong buy
- Forward EPS
- $3.48
- EPS estimate, current year
- $0.80
Shares and trading
- Beta
- -0.03
- Average volume
- 889.22K
- Shares outstanding
- 176.82M
- Float
- 97.58M
- Institutional ownership
- 26.6%
- Insider ownership
- 59.6%